A vital part of academic research is networking, and one of the ways researchers share their work is at professional conferences. Universities and departments sponsor these conferences where groundbreaking papers are given (usually long before publishing) and colleagues from around the world share insights. The University of California Los Angeles has world-class scientists and other thinkers in its ranks, and Los Angeles seems a natural hub for gathering great minds for this important mode of networking. Unfortunately, UCLA has lacked meeting facilities on par with the caliber of its faculty and research labs. That is about to be remedied, thanks to a commitment by the UC Regents and a generous donor pledge to build a new conference center with a 250-bed hotel right on campus and near existing facilities. According to UCLA Chancellor Gene Block:
Oracle Corporation is a Northern California computer technology giant with its world headquarters in the San Francisco Bay Area's Silicon Valley. From its wildly popular OpenWorld tech conference event held annually in San Francisco to its America's Cup sailboat that can be seen tacking across the Bay to and from the Golden Gate Yacht Club on a nice day, Oracle maintains a strong presence in the Bay Area, even beyond its extensive Redwood City campus. But that doesn't mean the company's Chairman of the Board (and former CFO) Jeff Henley lacks the vision to see that one of California's great strengths as far as technology goes is in the University of California System, and that strength comes from leveraging its power and resources across the state. That's why Henley and his wife have just committed $50M to fund a new science building, labs and faculty salaries on the UC Santa Barbara campus, where Henley got his undergraduate education.
There's been a lot of news coming out of Chicago this week from the annual meeting of the American Association for Cancer Research (AACR). Two announcements concerning prostate cancer research are especially worth broadcasting. An Ann Arbor pathologist, Arul M. Chinnaiyan, of the University of Michigan Comprehensive Cancer Center, will be leading a "dream team" of specialists from 5 of the top cancer research institutes in the world in a $10M, 3-year research project titled “Precision Therapy for Advanced Prostate Cancer.” The funding comes from AACR partner, Stand Up To Cancer (SU2C), and the Prostate Cancer Foundation (PCF). Heading up the team with Dr. Chinnaiyan is Dr. Charles L. Sawyers of Memorial Sloan-Kettering Cancer Center in New York.
Tags: University of Michigan, Midwest, Bioresearch, cancer research, nanotechnology, genome research, genomic medicine, 2012, Ann Arbor, BioResearch Product Faire Event, Funding, Research Funding, Conference, MI, science event, scientific conference, science current event, scientific events, UMich, Cancer Center, science research funding